Avalo Therapeutics

United States
Barbourmeade, Kentucky, United States, 20850

Company profile

Avalo Therapeutics company profile

Avalo Therapeutics is a clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize highly targeted therapeutics in areas of significant unmet clinical need.

Business identity

Contact email
[email protected]
Phone number
+1 610-254-4205
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2011-01-01, Year

Headquarters

Postal code
20850
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
4
Total equity funding
$231.5M
Last funding
Post IPO Equity / $69.4M / 2024-11-12
Last equity funding
Post IPO Equity / $69.4M
Investors
7
Lead investors
2
Founders
1
Articles
111
Exited on
2015-10-15

Founders and investors

Founders

Isaac Blech

Lead investors

Commodore CapitalTCG Crossover

Investors

Commodore CapitalDeep Track CapitalOrbiMedRA Capital ManagementTCG Crossover